These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 34121323)

  • 1. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
    Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K
    J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
    Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP
    Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854
    [No Abstract]   [Full Text] [Related]  

  • 3. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.
    Yu C; Yang L; Cai M; Zhou F; Xiao S; Li Y; Wan T; Cheng D; Wang L; Zhao C; Huang X
    J Cell Mol Med; 2020 Jan; 24(2):1568-1577. PubMed ID: 31778025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
    Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
    Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
    Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
    J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
    Nishimura T; Nakata A; Chen X; Nishi K; Meguro-Horike M; Sasaki S; Kita K; Horike SI; Saitoh K; Kato K; Igarashi K; Murayama T; Kohno S; Takahashi C; Mukaida N; Yano S; Soga T; Tojo A; Gotoh N
    Oncogene; 2019 Apr; 38(14):2464-2481. PubMed ID: 30532069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications.
    Ju HQ; Lu YX; Chen DL; Zuo ZX; Liu ZX; Wu QN; Mo HY; Wang ZX; Wang DS; Pu HY; Zeng ZL; Li B; Xie D; Huang P; Hung MC; Chiao PJ; Xu RH
    J Natl Cancer Inst; 2019 Jun; 111(6):584-596. PubMed ID: 30534944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.
    Li Q; Yang F; Shi X; Bian S; Shen F; Wu Y; Zhu C; Fu F; Wang J; Zhou J; Chen Y
    FEBS Open Bio; 2021 Oct; 11(10):2845-2857. PubMed ID: 34231329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer.
    Liu X; Liu S; Piao C; Zhang Z; Zhang X; Jiang Y; Kong C
    Cancer Sci; 2021 Dec; 112(12):4909-4919. PubMed ID: 34632667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
    Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
    Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
    Lin H; Huang B; Wang H; Liu X; Hong Y; Qiu S; Zheng J
    Cell Physiol Biochem; 2018; 51(2):991-1000. PubMed ID: 30466107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
    Yan Y; Zhang D; Lei T; Zhao C; Han J; Cui J; Wang Y
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):928-936. PubMed ID: 31209892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC.
    Geng QQ; Wu QF; Zhang Y; Zhang GJ; Fu JK; Chen NZ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9473-9479. PubMed ID: 33015789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.
    Li G; Wu J; Li L; Jiang P
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 18. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
    Yao Y; Hua Q; Zhou Y
    Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
    Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-4732-5p/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma
    Hu Y; Bai J; Zhou D; Zhang L; Chen X; Chen L; Liu Y; Zhang B; Li H; Yin C
    Mol Omics; 2022 Jun; 18(5):417-429. PubMed ID: 35388387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.